Pfizer is committed to developing breakthroughs that change patients’ lives. Today, Pfizer UK offers a diverse portfolio to patients including over 20 antibacterial and antifungal medicines. With infectious disease continuing to be a threat to global health, Pfizer is supporting the appropriate use of antibacterial/antifungal agents to protect patient health.

PP-CRB-GBR-1530 | April 2022